Market Overview:
The global urolithiasis management device market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of urolithiasis, technological advancements in lithotripsy devices, and rising demand for minimally invasive procedures. Based on type, the global urolithiasis management device market is segmented into extracorporeal shock wave lithotripsy (ESWL), intracorporeal lithotripsy, percutaneous nephrolithotomy (PCNL), and other treatments. ESWL is the most commonly used treatment for urolithiasis and accounted for the majority of the share in 2017. However, PCNL is expected to grow at a higher CAGR during the forecast period as it offers several advantages over other treatments such as shorter hospital stay, lower complication rates, and faster stone clearance rates. Based on application, hospitals accounted for majority of share in 2017 followed by clinics.
Product Definition:
A urolithiasis management device is a medical tool that is used to remove stones from the urinary tract. These devices can be either manual or mechanical, and are often used to break up and remove large stones. They are typically inserted into the urinary tract through the urethra, and can be used to clear out obstructions and help improve urine flow.
Extracorporeal Shock Wave Lithotripsy (Eswl):
Extracorporeal shock wave lithotripsy (ESWL) is a minimally invasive procedure used for the treatment of urolithiasis. It uses high-pressure shock waves to break up stones into smaller pieces allowing their easier passage through the urinary tract and bladder. This helps in the natural stone passageway and prevents any future blockage.
Intracorporeal Lithotripsy:
Intracorporeal lithotripsy is a technique used to remove kidney stones. It uses a laser beam to break up the stones into smaller pieces allowing them to pass out of the body more quickly and easily. This treatment can be done on an outpatient basis as there are no side effects associated with it.
Application Insights:
Based on the application, the global urolithiasis management device market is segmented into hospitals, clinics and other. The hospitals segment dominated the market in 2017 owing to factors such as availability of advanced healthcare facilities and highly skilled staff. In addition, a large number of stone patients are referred from community settings due to advanced diagnostic capabilities coupled with effective treatment options.
The clinics segment is expected to grow at a lucrative rate during the forecast period owing to increasing awareness about stone disease & its symptoms among general practitioners (GPs). Furthermore, rising prevalence of chronic diseases such as kidney stones and bladder stones along with growing incidences of overactive bladders are anticipated to boost product demand in near future.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable healthcare infrastructure, high awareness levels about urolithiasis treatment options, and availability of highly skilled physicians. Moreover, increasing government initiatives for raising public awareness is also expected to drive regional growth over the forecast period. For instance, Urolithiasis Treatment with Extracorporeal Shock Wave Lithotripsy (ETSwl) program was launched by North American Society of Stone Dentistry to raise awareness among patients and clinicians regarding lithotripsy procedure through ETSwl campaign.
Asia Pacific is expected to grow at a lucrative rate during the forecast period due to rising disposable income coupled with growing target population base in this region. In addition, improving healthcare facilities and economic development are some other factors contributing toward regional growth during the estimated time span.
Growth Factors:
- Increasing incidence of urolithiasis
- Growing awareness about the benefits of early diagnosis and treatment
- Rising demand for minimally invasive procedures
- Technological advancements in lithotripsy devices
- Growing number of urologists who are skilled in using lithotripsy devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Urolithiasis Management Device Market Research Report
By Type
Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments
By Application
Hospitals, Clinics, Other
By Companies
Allengers Medical Systems Ltd., Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical, ConMed Corporation, DirexGroup, Dornier MedTech GmbH, Guangzhou Potent Optotronic Technology Co., Ltd., HealthTronics, Inc., Karl Storz GmbH & Co. KG, Lumenis, Olympus Corporation, Richard Wolf, Siemens Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Urolithiasis Management Device Market Report Segments:
The global Urolithiasis Management Device market is segmented on the basis of:
Types
Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allengers Medical Systems Ltd.
- Boston Scientific Corporation
- C.R. Bard, Inc.
- Cook Medical
- ConMed Corporation
- DirexGroup
- Dornier MedTech GmbH
- Guangzhou Potent Optotronic Technology Co., Ltd.
- HealthTronics, Inc.
- Karl Storz GmbH & Co. KG
- Lumenis
- Olympus Corporation
- Richard Wolf
- Siemens Healthcare
Highlights of The Urolithiasis Management Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extracorporeal Shock Wave Lithotripsy (Eswl)
- Intracorporeal Lithotripsy
- Percutaneous Nephrolithotomy
- Other Treatments
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Urolithiasis Management Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A urolithiasis management device (UMD) is a medical device that helps to treat and prevent urinary stones. UMDs can be inserted into the bladder to remove stones, or they can be placed on the outside of the bladder to help push them out.
Some of the major companies in the urolithiasis management device market are Allengers Medical Systems Ltd., Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical, ConMed Corporation, DirexGroup, Dornier MedTech GmbH, Guangzhou Potent Optotronic Technology Co., Ltd., HealthTronics, Inc., Karl Storz GmbH & Co. KG, Lumenis, Olympus Corporation, Richard Wolf, Siemens Healthcare.
The urolithiasis management device market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Urolithiasis Management Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Urolithiasis Management Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Urolithiasis Management Device Market - Supply Chain
4.5. Global Urolithiasis Management Device Market Forecast
4.5.1. Urolithiasis Management Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Urolithiasis Management Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Urolithiasis Management Device Market Absolute $ Opportunity
5. Global Urolithiasis Management Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Urolithiasis Management Device Market Size and Volume Forecast by Type
5.3.1. Extracorporeal Shock Wave Lithotripsy (Eswl)
5.3.2. Intracorporeal Lithotripsy
5.3.3. Percutaneous Nephrolithotomy
5.3.4. Other Treatments
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Urolithiasis Management Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Urolithiasis Management Device Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Urolithiasis Management Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Urolithiasis Management Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Urolithiasis Management Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Urolithiasis Management Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Urolithiasis Management Device Demand Share Forecast, 2019-2026
9. North America Urolithiasis Management Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Urolithiasis Management Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Urolithiasis Management Device Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Urolithiasis Management Device Market Size and Volume Forecast by Type
9.7.1. Extracorporeal Shock Wave Lithotripsy (Eswl)
9.7.2. Intracorporeal Lithotripsy
9.7.3. Percutaneous Nephrolithotomy
9.7.4. Other Treatments
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Urolithiasis Management Device Demand Share Forecast, 2019-2026
10. Latin America Urolithiasis Management Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Urolithiasis Management Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Urolithiasis Management Device Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Urolithiasis Management Device Market Size and Volume Forecast by Type
10.7.1. Extracorporeal Shock Wave Lithotripsy (Eswl)
10.7.2. Intracorporeal Lithotripsy
10.7.3. Percutaneous Nephrolithotomy
10.7.4. Other Treatments
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Urolithiasis Management Device Demand Share Forecast, 2019-2026
11. Europe Urolithiasis Management Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Urolithiasis Management Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Urolithiasis Management Device Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Urolithiasis Management Device Market Size and Volume Forecast by Type
11.7.1. Extracorporeal Shock Wave Lithotripsy (Eswl)
11.7.2. Intracorporeal Lithotripsy
11.7.3. Percutaneous Nephrolithotomy
11.7.4. ther Treatments
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Urolithiasis Management Device Demand Share, 2019-2026
12. Asia Pacific Urolithiasis Management Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Urolithiasis Management Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Urolithiasis Management Device Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Urolithiasis Management Device Market Size and Volume Forecast by Type
12.7.1. Extracorporeal Shock Wave Lithotripsy (Eswl)
12.7.2. Intracorporeal Lithotripsy
12.7.3. Percutaneous Nephrolithotomy
12.7.4. Other Treatments
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Urolithiasis Management Device Demand Share, 2019-2026
13. Middle East & Africa Urolithiasis Management Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Urolithiasis Management Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Urolithiasis Management Device Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Urolithiasis Management Device Market Size and Volume Forecast by Type
13.7.1. Extracorporeal Shock Wave Lithotripsy (Eswl)
13.7.2. Intracorporeal Lithotripsy
13.7.3. Percutaneous Nephrolithotomy
13.7.4. Other Treatments
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Urolithiasis Management Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Urolithiasis Management Device Market: Market Share Analysis
14.2. Urolithiasis Management Device Distributors and Customers
14.3. Urolithiasis Management Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allengers Medical Systems Ltd.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. C.R. Bard, Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cook Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ConMed Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. DirexGroup
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dornier MedTech GmbH
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Guangzhou Potent Optotronic Technology Co., Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. HealthTronics, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Karl Storz GmbH & Co. KG
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lumenis
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Olympus Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Richard Wolf
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Siemens Healthcare
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
